Publikationen, an denen er mitarbeitet EDUARDO PÉREZ GÓMEZ (19)

2024

  1. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  2. Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling

    Cancers, Vol. 15, Núm. 9

2022

  1. An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer

    Molecular Therapy - Nucleic Acids, Vol. 30, pp. 553-568

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

2018

  1. Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer

    Biochemical Pharmacology, Vol. 157, pp. 285-293

2016

  1. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

2015

  1. Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts

    SpringerPlus, Vol. 4, Núm. 1

  2. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144

  3. New inhibitors of angiogenesis with antitumor activity in vivo

    Journal of Medicinal Chemistry, Vol. 58, Núm. 9, pp. 3757-3766

  4. Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer

    Journal of the National Cancer Institute, Vol. 107, Núm. 6

2014

  1. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling

    Journal of Biological Chemistry, Vol. 289, Núm. 32, pp. 21960-21972

2013

  1. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

    Oncogene, Vol. 32, Núm. 20, pp. 2534-2542

  2. The role of GPR55 in cancer

    endoCANNABINOIDS: Actions at Non-CB1/CB2 Cannabinoid Receptors (Springer New York), pp. 115-133

2012

  1. Cannabinoids: A new hope for breast cancer therapy?

    Cancer Treatment Reviews, Vol. 38, Núm. 7, pp. 911-918

2011

  1. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

    Oncogene, Vol. 30, Núm. 2, pp. 245-252

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

  2. The putative cannabinoid receptor GPR55 participates in the control of cancer cell proliferation

    EJC SUPPLEMENTS